Mental Health DailyResearch. Evidence. Perspective.Published research on Drugs.
Maxalt (Rizatriptan) is a pharmaceutical medication engineered by Merck & Co. for the treatment of migraine headaches (with or without aura). It received FDA approval in 1998 as an abortive …
Read articleRelpax (Eletriptan) is a medication manufactured by Pfizer Inc. for the acute treatment of migraine headaches (with or without aura) in adults. It was initially approved by the FDA in 2002 a…
Read articleNortriptyline is a tricyclic antidepressant (TCA) that was initially FDA approved in 1964 (under the brand name “Pamelor”) for the treatment of major depression. It is regarded as chemical s…
Read articleAmitriptyline (brand name “Elavil”) is a medication that was initially approved by the FDA in 1961 for the treatment of major depressive disorder. Due to its three-ring chemical structure, i…
Read articleSumatriptan (brand names “Imitrex”) is a synthetic medication that was initially approved in 1991 for the treatment of migraine and cluster headaches. Chemically, it is classified as a “trip…
Read articleFioricet is a medication approved by the FDA for the treatment of three specific types of headaches including: tension, muscle contraction, and post-dural puncture. It contains a unique blen…
Read articleFioricet is a brand name medication comprised of the following ingredients: butalbital (50 mg), acetaminophen (300 mg), and caffeine (40 mg). The combination of a barbiturate (butalbital), a…
Read article